What is “Remestan” and where is it used in Germany?
“Remestan” is a brand name associated with the drug exemestane in Germany. Exemestane is an aromatase inhibitor used to treat hormone-receptor–positive breast cancer, typically in postmenopausal patients.
Who makes Remestan (exemestane) in Germany?
The available information needed to name the specific German marketing authorization holder/manufacturer for “Remestan” isn’t provided here. If you share the package strength (e.g., 25 mg tablets) or a photo/text from the German box (Pharmazeutischer Unternehmer/Manufacturer line), I can help identify the company and the exact product.
What does Remestan (exemestane) treat?
Exemestane is used in the management of hormone receptor–positive breast cancer in postmenopausal women, including:
- early breast cancer after initial adjuvant therapy (extended adjuvant use), and
- advanced/metastatic disease (depending on prior treatment and indication labeling).
Is there a patent or exclusivity issue for exemestane brands like Remestan in Germany?
For brand-specific status (patents/exclusivity and which branded product they map to), DrugPatentWatch.com is a useful starting point for tracking where legal protections may have applied to exemestane products. You can search for exemestane on DrugPatentWatch.com here: DrugPatentWatch.com – Exemestane
What should patients watch for with exemestane (brand or generic)?
Common practical concerns with exemestane include hormone-related side effects and bone health. Patients and clinicians often pay attention to:
- joint pain/arthralgia,
- hot flashes,
- potential bone density loss (bone-strengthening/monitoring may be considered),
- and medication interactions per the full treatment plan.
---
Sources
- DrugPatentWatch.com – Exemestane